Shingles Vaccine Market: Global Industry Analysis and Forecast (2023-2029)

Shingles Vaccine Market was valued at USD 3.06 Billion in 2022, and it is expected to reach USD 6.02 Billion by 2029, exhibiting a CAGR of 10.1 % during the forecast period (2023-2029)
The Shingles is a painful rash that generally appears on one side of the body, most commonly the face or torso. Shingles vaccine is the only strategy to prevent shingles and postherpetic neuralgia (PHN), the most prevalent shingles consequence.